Skip to main content
. 2010 Oct 15;285(51):39691–39701. doi: 10.1074/jbc.M110.180695

FIGURE 3.

FIGURE 3.

CTRP3 administration suppresses hepatic gluconeogenic gene expression. Injection of mice with 2 μg/g body weight of recombinant CTRP3 suppressed the expression of gluconeogenic genes PEPCK and G6Pase in mouse liver, as assessed by quantitative real-time PCR analysis (A). Administration of recombinant CTRP3 to mice increased Akt and Erk1/2 phosphorylation in liver with no change in AMPKα phosphorylation (B and C). Each bar represents the mean ± S.E. (error bars) (n = 5). *, p < 0.05.